CardioSecur
- Company typePrivate
- Founded2008
- HeadquartersFrankfurt, Germany
- Headcount11–50
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
CardioSecur firmographics
Firmographics- Name
- CardioSecur
- Legal name
- Personal MedSystems GmbH
- Website
- https://cardiosecur.com
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Where CardioSecur is headquartered
LocationHeadquarters
- HQ city
- Frankfurt
- HQ country
- Germany
- HQ region
- Europe
Offices5 records
Markets served
CardioSecur business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Infrastructure, Operations
Revenue model
- ECG Device Sales: Sale of mobile ECG hardware devices (CardioSecur Active, CardioSecur Pro 12/22 leads, CardioSecur Pace) along with accessories. One-time purchase model for hardware.
- Subscription Services: Monthly subscription services for data access, physician connectivity, and platform usage. Minimum term of 1 month with monthly billing. Includes ISP access, ECG storage, and physician communication features.
- Server-to-Server Integration: Optional paid add-on service for physicians providing integrated server-to-server communication transmitting data directly from ISP to physician's patient information system.
- B2B/Enterprise Solutions: Enterprise agreements with aviation partners (airlines) and mHealth platform providers for inflight medical emergencies and biosignal analysis networks.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Monthly subscription with 1-month minimum term |
| One time/ perpetual license | Pay-as-you-go | One-time device purchase |
Go-to-market motion3 records
Distribution channels6 records
Marketing channels6 records
CardioSecur product offering
Product offeringCore offering
CardioSecur (Personal MedSystems GmbH) develops and sells mobile ECG hardware and software that allow patients and physicians to record clinical 12-, 15-, and 22-lead ECGs using a streamlined 4-electrode system connected via Bluetooth to iOS apps. The offering combines one-time hardware purchases (CardioSecur Active for patients, CardioSecur Pro 12/22-leads and Pace for clinicians, CardioSecur Aviation for airlines) with recurring subscription services for the ISP cloud platform, physician connectivity, ECG storage, and server-to-server integration.
Product overview
CardioSecur is a mobile ECG technology platform consisting of hardware devices and software applications for cardiac monitoring. The portfolio centers on CardioSecur Active for patients and CardioSecur Pro (available in 12-lead and 22-lead configurations) for physicians, all utilizing a streamlined 4-electrode system that achieves full 12+ lead ECG coverage. Additional offerings include CardioSecur Pace for electrophysiology procedures, Cardio Secur Vector-ECGi for advanced cardiac imaging, CardioSecur Aviation for airline in-flight emergencies, and the ECG Cockpit platform for centralized data analysis. All products connect through the ISP (Internet Service Platform) which enables patient-physician data sharing with automatic alerts for abnormal readings. The company has pioneered the first smartphone-based 22-lead mobile ECG (12 standard leads plus V7-V9 and VR3-VR9), delivering hospital-quality ECG capability in a portable form factor.
Differentiator
Problem solved
Functional benefit
Brands
- CardioSecur Active: Mobile ECG device for smartphones enabling patients to record clinical 12-lead ECG at home
- CardioSecur Pro - 12-leads
- CardioSecur Pro - 22-leads
- CardioSecur Pace
- Cardio Secur Vector-ECGi
- CardioSecur Aviation
- ECG Cockpit
Products and services
- CardioSecur Active Smartphone-based mobile ECG device that lets patients record a clinical 12-, 15-, or 22-lead ECG at the moment symptoms occur and receive an immediate green/yellow/red recommendation on whether medical attention is required, targeted at consumers managing chest pain, suspected arrhythmia, or post-heart-attack prevention.
- CardioSecur Pro - 12-leads Professional ultralight, iOS-based 12-lead ECG system using only 4 electrodes in landmark spots, designed for daily clinical use by physicians with reproducible electrode placement across any patient anatomy.
- CardioSecur Pro - 22-leads Advanced professional 22-lead ECG system providing standard 12 leads plus V7-V9 and VR3-VR9 for maximum ischemia detection and arrhythmia localization, exceeding conventional 12-lead ECG coverage for cardiology use.
- CardioSecur Aviation Ultra-light, easy-to-use 12+ lead ECG kit designed for in-flight medical emergencies on commercial airlines, developed in cooperation with airlines to increase passenger safety and prevent costly unnecessary flight diversions.
- ECG Cockpit Digital infrastructure platform that dissolves ECG data blind spots and brings 12+ lead ECG analysis to remote locations via centralized visualization and monitoring of ECG data across multiple settings, targeted at airlines, clinics, and mHealth operators.
- CardioSecur ISP (Integrated Service Platform) Internet-based service platform enabling physicians to view, download, save, and print patient ECG data with password-protected access, automatic email notifications for abnormal readings, ECG storage, and optional paid server-to-server integration transmitting data directly from ISP into a physician's patient information system.
Quantifiable outcome
- Immediate action recommendation after ECG measurement
Companies that use CardioSecur
Customer profileNamed customers7 records
Segments5 records
Ideal customer profiles4 records
CardioSecur technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature7 records
CardioSecur partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered flagship, core and minor.
- LufthansaflagshipAviation partnership for inflight medical emergencies. CardioSecur provides 12+ lead ECG technology designed by airlines to increase passenger safety and prevent costly unnecessary diversions.
- Etihad AirwaysflagshipAviation partnership for inflight medical emergencies using CardioSecur ECG technology.
- Qatar AirwaysflagshipAviation partnership for inflight medical emergencies using CardioSecur ECG technology.
- Virgin AtlanticflagshipAviation partnership for inflight medical emergencies using CardioSecur ECG technology.
- IATAcoreInternational Air Transport Association partnership for aviation medical standards and ECG technology adoption in aviation industry.
- EbaaminorMedical partner for cardiac monitoring services.
- Health InsurerscoreHealth insurance companies provide voucher programs covering CardioSecur services, enabling reimbursement for patients and creating distribution channel.
- Hetzner Online GmbHcoreData center operator hosting CardioSecur platform and patient medical data. Server locations in Nuremberg, Falkenstein Vogtland (Germany), and Helsinki (Finland).
- Academic PartnerscoreScientific partners collaborating on continuous improvement of CardioSecur products through research and clinical studies.
- Practices and ClinicscoreNetwork of doctors and partner practices using CardioSecur for patient monitoring and continuous product improvement through clinical feedback.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
CardioSecur competitors and assessment
Company assessmentDirect peers
- Eko Health: Eko combines digital stethoscopes with ECG and AI-enabled cardiac analysis for clinicians — overlapping in the connected ECG and AI-augmented cardiac diagnostics space.
- AliveCor: AliveCor's KardiaMobile is a consumer/clinical single-lead ECG device with smartphone connectivity and subscription physician interpretation — directly comparable to CardioSecur Active in target market and business model.
- iRhythm Technologies: iRhythm's Zio patch is a clinical-grade ambulatory cardiac monitor using biosensor technology and AI-based analysis — competing in the same cardiac monitoring/diagnostics category with a recurring service revenue model.
- Withings: Withings sells consumer ECG-enabled devices (BPM Core, Move ECG, Body Scan) integrated with a health platform — competing with CardioSecur Active in the consumer heart-monitoring category.
Broad incumbents
- Philips (BioTelemetry / Cardiac Monitoring): Philips acquired BioTelemetry to offer ambulatory cardiac monitoring (MCOT, Holter) and is a hospital ECG incumbent — overlapping in mobile and clinical cardiac diagnostics but at much larger scale and scope.
- GE HealthCare: GE HealthCare's MAC series (e.g., MAC 800) is the dominant resting-ECG system in hospitals globally — a broad incumbent competing with CardioSecur Pro in the clinical 12-lead segment.
- Preventice Solutions (Boston Scientific): Now part of Boston Scientific, Preventice offers BodyGuardian remote cardiac monitoring — comparable to CardioSecur's clinical/remote patient monitoring offering, though under a much larger corporate parent.
- Apple (Apple Watch ECG): Apple Watch provides consumer-grade single-lead ECG with FDA clearance and massive installed base — a broad incumbent in personal cardiac monitoring that competes with CardioSecur Active at the consumer end.
Emerging players
- Bittium (Faros): Bittium Faros is a portable ECG/HRV device targeted at clinical and research cardiac monitoring — a focused regional/niche player with overlap in the mobile cardiac diagnostics space.
- HeartBeam: HeartBeam is developing a credit-card-sized 3D-vector ECG for at-home detection of heart attacks — an emerging player targeting similar use cases (chest pain, remote MI detection) as CardioSecur Active.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
CardioSecur social profiles
Digital presenceCardioSecur compliance and trust
Trust signalCompliance3 records
CardioSecur financial estimates
Financial estimateRevenue estimate
Valuation estimate
CardioSecur leadership team
Management profileNumber of profiles
Profiles4 records
CardioSecur funding detail
Funding detailFunding overview
Funding rounds2 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CardioSecur M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CardioSecur
What does CardioSecur do?
CardioSecur (Personal MedSystems GmbH) develops and sells mobile ECG hardware and software that allow patients and physicians to record clinical 12-, 15-, and 22-lead ECGs using a streamlined 4-electrode system connected via Bluetooth to iOS apps. The offering combines one-time hardware purchases (CardioSecur Active for patients, CardioSecur Pro 12/22-leads and Pace for clinicians, CardioSecur Aviation for airlines) with recurring subscription services for the ISP cloud platform, physician connectivity, ECG storage, and server-to-server integration.
Is CardioSecur a public or private company?
CardioSecur is a private company. It is classified as venture growth investor backed and is currently operating.
When was CardioSecur founded?
CardioSecur was founded in 2008. It employs 11 to 50 people.
Where is CardioSecur based?
CardioSecur is headquartered in Frankfurt, Germany, in the Europe region.
How does CardioSecur make money?
Four revenue lines are on record. ECG Device Sales are the primary driver. The others are subscription Services, server-to-Server Integration and B2B/Enterprise Solutions.
Who are CardioSecur's main competitors?
Direct peers on record are Eko Health, AliveCor, iRhythm Technologies and Withings. Broad incumbents are Philips (BioTelemetry / Cardiac Monitoring), GE HealthCare, Preventice Solutions (Boston Scientific) and Apple (Apple Watch ECG). Emerging players are Bittium (Faros) and HeartBeam.
Does CardioSecur have an API?
No public API is recorded for CardioSecur.